This is a demo store. No orders will be fulfilled.

Life Sciences

Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas

The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.

Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.

The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.

We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.

We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.

  1. 02 Feb 2017  |  Europe  |  Mega Trends

    European Next-generation Sequencing Services Market, Forecast to 2023

    Exome and RNA Sequencing Focusing on Applied Markets to Drive Growth

    The study aims to analyse the key disruptions transforming the next-generation sequencing (NGS) services market in Europe and profile regional markets with significant growth potential Research Scope: • Revenue Forecasts • Regional Market Dynamics • Market Share Analysis and Top Countries • Key Trends and Growth Opportunities • Game-chan...

    $4,950.00
  2. 24 Jan 2017  |  Asia Pacific  |  Market Research

    Game-changing Strategies of APAC Pharma Companies

    Growing Focus on Specific Therapy Areas and Shift Towards Value-based Delivery Model Expected to Boost Pharma Market

    Frost & Sullivan has recently completed a comprehensive analysis on the current and future strategic imperatives of game-changing Asia-Pacific (APAC) pharmaceutical companies. The analysis primarily focuses on the changing trends in the pharmaceutical industry with respect to drug research and development, manufacturing, supply chain, and marketing...

    $1,500.00
  3. 17 Jan 2017  |  Europe  |  Market Research

    Game-changing Strategies of European Pharma Companies

    Strong Focus on Digital Footprint and Beyond-the-pill Services Propel Companies to Innovate and Stay on the Growth Trajectory

    Frost & Sullivan has recently completed a comprehensive analysis on the current and future strategic imperatives of game-changing European pharmaceutical companies. The analysis primarily focuses on the changing trends in the pharmaceutical industry with respect to drug research and development, manufacturing, supply chain, and marketing. The study...

    $1,500.00
  4. 14 Nov 2016  |  Asia Pacific  |  Market Research

    Analysis of the Indonesian Clinical Laboratories Market

    Increase in Test Volumes Due to Universal Health Coverage will Boost Market Growth Across All Segments

    Given the ever-increasing cost of care, healthcare delivery is moving towards decentralisation. Service delivery from health settings such as mobile clinics, rapid retail clinics, and home settings demands the use of new-age clinic laboratory diagnostics. Effective delivery of healthcare services has created a business and technology convergence be...

    $1,500.00
  5. 11 Nov 2016  |  Asia Pacific  |  Market Research

    Analysis of the Australian Clinical Laboratory Market

    Evolving Business Model—Technological Advances will Drive the Market

    Given the ever increasing cost of care, healthcare delivery is moving towards decentralisation. Service delivery from healthcare settings such as mobile clinics, rapid retail clinics, and home settings demands the use of new-age clinical laboratory diagnostics. The effective delivery of healthcare services has created a business and technology conv...

    $1,500.00
  6. 15 Jul 2016  |  Europe  |  Market Research

    Snapshot of the Mobile Health (mHealth) Market Opportunity in Europe

    Sector Convergence is Generating Growth Opportunities Across the Value Chain

    Mobile Health (mHealth) can play a vital role in European healthcare systems by improving communication between providers and patients and enabling patients to participate more actively in their health and wellness. At both EU and country levels, various pilot projects have demonstrated positive outcomes—both qualitative and quantitative—result...

    $1,500.00
  7. 12 Jul 2016  |  Asia Pacific  |  Market Research

    Analysis of the APAC Health Information Exchange Market

     

    This research service analyzes the health information exchange (HIE) market in Asia-Pacific. Driven primarily by governments, the region is embarking on the next phase of healthcare IT transformation, investing in decentralizing patient information by enabling data exchange among established electronic medical record (EMR) and electronic health rec...

    $4,950.00
  8. 01 Jul 2016  |  Europe  |  Market Research

    Western Europe Point-of-Care Testing (POCT) Market

    Point-of-care testing is an integral part of the IVD market that is rapidly evolving into a preferred testing mode in the EU region. POCT is a segment that presents growth opportunities for a cross-section of players, ranging from OEMs to data integrators to technology vendors. The stakeholders need to be abreast of the challenges posed by the indu...

    $4,950.00
  9. 24 Jun 2016  |  Europe  |  Market Research

    Business Analytics in Life Sciences

    The Time is Ripe for a Technology Revamp in Clinical Trials

    The drastic increase in the number of clinical trials performed worldwide is leading to a sharp rise in R&D expenditure incurred by life sciences companies. To overcome this challenge, companies are targeting clinical trials to achieve higher efficiencies, which will bring new drugs faster to market and reduce R&D cost burden. The solution lies in ...

    $3,000.00
  10. 31 May 2016  |  Asia Pacific  |  Market Research

    2016 Indonesia Transformational Health Insights

    Current Trends and Challenges Encountered in the Road to Achieving Universal Healthcare Coverage

    Indonesia is expected to see a substantial rise in healthcare spending driven by rapid urbanization, a growing middle class population, and an increasing prevalence of chronic diseases. Government initiatives to provide universal healthcare coverage (UHC) by 2019 are one of the key reasons for making Indonesia an attractive healthcare market. All t...

    $1,500.00